🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Dr. Reddy’s Laboratories Ltd ADR (RDY)

NYSE
Currency in USD
15.08
-0.01(-0.06%)
Real-time Data
RDY Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
Fair Value
Day's Range
15.0515.17
52 wk Range
12.9016.89
Prev. Close
15.09
Open
15.12
Day's Range
15.05-15.17
52 wk Range
12.9-16.89
Volume
61,972
Average Volume (3m)
794,567
1-Year Change
13.72%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
RDY Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
1,303.86
Upside
+8,534.83%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

Dr. Reddy’s Labs ADR Company Profile

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company’s Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Employees
27048

Compare RDY to Peers and Sector

Metrics to compare
RDY
Peers
Sector
Relationship
P/E Ratio
20.0x38.7x−0.6x
PEG Ratio
4.310.960.00
Price/Book
3.5x6.2x2.6x
Price / LTM Sales
3.6x4.7x3.3x
Upside (Analyst Target)
−2.4%9.3%45.3%
Fair Value Upside
Unlock−13.7%6.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 64.05
Dividend Yield
0.53%
Industry Median 1.73%
Annualised payout
0.0808
Paid annually
5-Years Growth
-
Growth Streak

People Also Watch

5
AXBKY
0.00%
60.20
RELIq
-1.79%
26.87
HMC
-3.14%
118.14
SRPT
-1.89%
6.61
ARRY
+6.61%

FAQ

What Is the Dr. Reddy’s Labs ADR (RDY) Stock Price Today?

The Dr. Reddy’s Labs ADR stock price today is 15.08

What Stock Exchange Does Dr. Reddy’s Labs ADR Trade On?

Dr. Reddy’s Labs ADR is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Dr. Reddy’s Labs ADR?

The stock symbol for Dr. Reddy’s Labs ADR is "RDY."

Does Dr. Reddy’s Labs ADR Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.54%.

What Is the Dr. Reddy’s Labs ADR Market Cap?

As of today, Dr. Reddy’s Labs ADR market cap is 12.63B.

What is Dr. Reddy’s Labs ADR Earnings Per Share?

The Dr. Reddy’s Labs ADR EPS is 64.05.

What Is the Next Dr. Reddy’s Labs ADR Earnings Date?

Dr. Reddy’s Labs ADR will release its next earnings report on 24 Jan 2025.

From a Technical Analysis Perspective, Is RDY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.